Brandon Couillard
Stock Analyst at Wells Fargo
(2.14)
# 1033
Out of 5,347 analysts
94
Total ratings
43.40%
Success rate
30.30%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MLAB Mesa Laboratories | Maintains: Underweight | 120 100 | 100.7 | -0.7% | 2 | May 30, 2025 | |
TECH Bio-Techne | Initiates Coverage On: Overweight | 59 | 48.4 | 21.9% | 1 | May 30, 2025 | |
MYGN Myriad Genetics | Downgrades: Equal-Weight | 22 6 | 4.2 | 42.86% | 2 | May 8, 2025 | |
MTD Mettler-Toledo Intl | Maintains: Equal-Weight | 1125 1200 | 1156.83 | 3.73% | 5 | May 5, 2025 | |
WGS GeneDx Holdings | Maintains: Equal-Weight | 105 78 | 71.25 | 9.47% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 580 570 | 402.75 | 41.53% | 5 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 135 116 | 111.9 | 3.66% | 17 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 130 102 | 90.43 | 12.79% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 75 60 | 36.69 | 63.53% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 320 270 | 227.06 | 18.91% | 6 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 25 22 | 12.92 | 70.28% | 4 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 415 420 | 348.99 | 20.35% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 280 240 | 189.87 | 26.4% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 285 260 | 180.93 | 43.7% | 4 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 77 80 | 69.96 | 14.35% | 3 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 28 24 | 16.99 | 41.26% | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 84 85 | 56.3 | 50.98% | 11 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 180 | 118.06 | 52.46% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 10 | 2.25 | 344.44% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 30 23 | 18.28 | 25.82% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 4 3 | n/a | n/a | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 2 | n/a | n/a | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 23 | n/a | n/a | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 13 | 0.75 | 1633.33% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 22 10 | n/a | n/a | 1 | Feb 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 440 540 | n/a | n/a | 3 | Mar 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 9 11 | 2.31 | 376.19% | 2 | Oct 13, 2017 |